Results 211 to 220 of about 18,314 (233)
Some of the next articles are maybe not open access.

Hypoxia-stabilized RIPK1 promotes cell death

Nature Cell Biology, 2023
Wei Ruan   +2 more
openaire   +2 more sources

Monitoring RIPK1 Phosphorylation in the TNFR1 Signaling Complex

2018
Receptor-interacting protein kinase 1 (RIPK1) is a component of the TNFR1 signaling complex (also known as complex I or TNFR-SC), where its ubiquitylation by cIAP1/2 and LUBAC serves to initiate prosurvival and proinflammatory responses through activation of the MAPK and NF-κB pathways. IKKα/β-mediated phosphorylation of RIPK1 in complex I was shown to
Dario, Priem   +2 more
openaire   +2 more sources

Sanofi buys into Denali’s RIPK1 drugs

C&EN Global Enterprise, 2018
In another sizable deal for Denali Therapeutics, Sanofi is paying $125 million to buy into a series of neuroinflammation compounds called RIPK1 inhibitors. The pact provides key funding for the molecules, which have potential activity across several diseases with large patient populations, including Alzheimer’s, multiple sclerosis, and arthritis.
openaire   +1 more source

Roles of RIPK1 as a stress sentinel coordinating cell survival and immunogenic cell death

Nature Reviews Molecular Cell Biology, 2023
Jarama Clucas, Pascal Meier
exaly  

Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target

Nature Reviews Drug Discovery, 2020
Lauren Mifflin, Junying Yuan
exaly  

Home - About - Disclaimer - Privacy